Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Am Heart J
    July 2021
  1. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    >> Share

    May 2021
  2. MAHFOUD F, Weber M, Schmieder RE, Lobo MD, et al
    Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
    Am Heart J. 2021 May 27. pii: S0002-8703(21)00144.
    >> Share

  3. STEVENS BR, Pepine CJ, Richards EM, Kim S, et al
    Depressive-hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
    Am Heart J. 2021 May 10:100540. doi: 10.1016/j.ahj.2021.
    >> Share

    January 2021
  4. MOGHADDAM N, Swiston JR, Tsang MY, Levy R, et al
    IMPACT OF TARGETED PULMONARY ARTERIAL HYPERTENSION THERAPY IN PATIENTS WITH COMBINED POST- AND PRE-CAPILLARY PULMONARY HYPERTENSION.
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00005.
    >> Share

    December 2020
  5. MILLS KT, Peacock E, Chen J, Zimmerman A, et al
    Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS): Rationale and design of a cluster-randomized trial.
    Am Heart J. 2020;230:13-24.
    >> Share

    October 2020
  6. NOWAK RM, Jacobsen G, Jr AL, Peacock WF, et al
    Outpatient versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute Myocardial Infarction: Findings from the HIGH-US Study.
    Am Heart J. 2020 Oct 27. pii: S0002-8703(20)30353.
    >> Share

  7. CHOW CK, Atkins ER, Billot L, Chalmers J, et al
    Ultra-low-dose quadruple combination blood pressure lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
    Am Heart J. 2020 Oct 2. pii: S0002-8703(20)30273.
    >> Share

    August 2020
  8. OREN O, Gersh BJ, Blumenthal RS
    Anticipating and curtailing the cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19.
    Am Heart J. 2020;226:1-3.
    >> Share

    July 2020
  9. MEIJS TA, Krings GJ, Saad A, Molenschot MMC, et al
    Epinephrine stress testing during cardiac catheterization in patients with aortic coarctation.
    Am Heart J. 2020;225:78-87.
    >> Share

    May 2020
  10. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Trial design of the RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs health system plus a collaborative/stepped care intervention to reduce hypertension disparities.
    Am Heart J. 2020;226:94-113.
    >> Share

    April 2020
  11. AESCHBACHER S, Mongiat M, Bernasconi R, Blum S, et al
    Aldosterone-to-renin ratio and blood pressure in young adults from the general population.
    Am Heart J. 2020;222:199-207.
    >> Share

    March 2020
  12. HUANG L, Tian M, Yu J, Li Q, et al
    Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS).
    Am Heart J. 2020;221:136-145.
    >> Share

    February 2020
  13. HAFF N, Lauffenburger JC, Morawski K, Ghazinouri R, et al
    The accuracy of self-reported blood pressure in the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial: Implications for pragmatic trials.
    Am Heart J. 2020;220:68-72.
    >> Share

    November 2019
  14. LORING Z, Shrader P, Allen LA, Blanco R, et al
    Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
    Am Heart J. 2019;219:21-30.
    >> Share

    July 2019
  15. OKEKE NL, Webel AR, Bosworth HB, Aifah A, et al
    Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).
    Am Heart J. 2019;216:91-101.
    >> Share

    June 2019
  16. JOSHI R, Agrawal T, Fathima F, Usha T, et al
    Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial.
    Am Heart J. 2019;216:9-19.
    >> Share

    April 2019
  17. SULLIVAN LT 2ND, Mulder H, Chiswell K, Shaw LK, et al
    Racial differences in long-term outcomes among black and white patients with drug-eluting stents.
    Am Heart J. 2019;214:46-53.
    >> Share

    November 2018
  18. GEENEN LW, Baggen VJM, Koudstaal T, Boomars KA, et al
    The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.
    Am Heart J. 2018;208:91-99.
    >> Share

    October 2018
  19. DAVISON WJ, Myint PK, Clark AB, Potter JF, et al
    Blood pressure differences between home monitoring and daytime ambulatory values and their reproducibility in treated hypertensive stroke and TIA patients.
    Am Heart J. 2018;207:58-65.
    >> Share

    September 2018
  20. EYSENCK W, van Zalen J, Freemantle N, Lloyd G, et al
    Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension and paroxysmal AF.
    Am Heart J. 2018 Sep 29. pii: S0002-8703(18)30279.
    >> Share

    August 2018
  21. LOPES RD, Barroso WKS, Brandao AA, Barbosa ECD, et al
    The First Brazilian Registry of Hypertension.
    Am Heart J. 2018 Aug 30. pii: S0002-8703(18)30255.
    >> Share

  22. WHITE WB, Jalil F, Wakefield DB, Kaplan RF, et al
    Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension.
    Am Heart J. 2018;205:21-30.
    >> Share

  23. CLAUDEL SE, Adu-Brimpong J, Banks A, Ayers C, et al
    Association between neighborhood-level socioeconomic deprivation and incident hypertension: A longitudinal analysis of data from the Dallas heart study.
    Am Heart J. 2018;204:109-118.
    >> Share

    July 2018
  24. PAGIDIPATI NJ, Hellkamp AS, Sharma PP, Wang TY, et al
    High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.
    Am Heart J. 2018;204:151-155.
    >> Share

  25. ZWIJNENBURG RD, Baggen VJM, Geenen LW, Voigt KR, et al
    The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Am Heart J. 2018;201:63-71.
    >> Share

    June 2018
  26. SCHWALM JR, McCready T, Lamelas P, Musa H, et al
    Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study.
    Am Heart J. 2018;203:57-66.
    >> Share

    May 2018
  27. MUKHTAR O, Cheriyan J, Cockcroft JR, Collier D, et al
    A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in
    Am Heart J. 2018;204:102-108.
    >> Share

    January 2018
  28. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    >> Share

    October 2017
  29. WAKSMAN R, Bakris GL, Steinvil A, Garcia-Garcia H, et al
    High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
    Am Heart J. 2017;192:76-84.
    >> Share

    July 2017
  30. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    >> Share

    June 2017
  31. NEAL B, Tian M, Li N, Elliott P, et al
    Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial.
    Am Heart J. 2017;188:109-117.
    >> Share

    April 2017
  32. VEMULAPALLI S, Deng L, Patel MR, Kilgore ML, et al
    National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Am Heart J. 2017;186:29-39.
    >> Share

  33. MORAWSKI K, Ghazinouri R, Krumme A, McDonough J, et al
    Rationale and design of the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial.
    Am Heart J. 2017;186:40-47.
    >> Share

    March 2017
  34. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    >> Share

  35. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    >> Share

  36. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    >> Share

  37. KHETAN A, Purushothaman R, Zullo M, Gupta R, et al
    Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India.
    Am Heart J. 2017;185:161-172.
    >> Share

    September 2016
  38. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    >> Share

  39. BHATNAGAR A, Bolli R, Johnstone BH, Traverse JH, et al
    Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Am Heart J. 2016;179:142-50.
    >> Share

  40. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    >> Share

    August 2016
  41. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    >> Share

  42. VEMULAPALLI S, Hellkamp AS, Jones WS, Piccini JP, et al
    Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial.
    Am Heart J. 2016;178:74-84.
    >> Share

  43. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    >> Share

  44. AKERBLOM A, Clare RM, Lokhnygina Y, Wallentin L, et al
    Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
    Am Heart J. 2016;178:1-8.
    >> Share

    July 2016
  45. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016